Pharma Journalist -

Cambrex announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point,…
Read More...

ProofPilot, the digital protocol automation platform for clinical trials, and Human API, the industry-leading platform enabling life sciences organizations to connect and convert…
Read More...

Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Read More...

Novavax, Inc. announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine has been recommended for expanded conditional marketing authorization (CMA) in the European Union (EU) as a…
Read More...

Novo Nordisk and Forma Therapeutics, Holdings Inc. announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per…
Read More...

SAE Media Group: key topics and presentations released for ahead of the Wearable Injectors and Connected Devices Conference SAE Media Group is proud to announce the 3rd Annual…
Read More...

Amneal Pharmaceuticals, Inc. announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for IPX203, a novel, oral formulation of…
Read More...

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions ("IPS"), a division of Interpace…
Read More...

Guardant Health, Inc. announced an expanded collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company, operating its biopharmaceuticals business in the…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for efanesoctocog alfa (BIVV001) for the treatment of hemophilia A,…
Read More...